A combination therapy with fludarabine, mitoxantrone and rituximab induces complete immunophenotypical remission in B-cell prolymphocytic leukaemia.

Source:http://linkedlifedata.com/resource/pubmed/id/18654781

Download in:

View as

Triples

General Info

PMID
18654781